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Introduction
Bone marrow biopsy (BMBx) and aspirat ion is  a 
fundamental part of the diagnostic workup of various benign 
and malignant hematological disorders. Improved via several 
variations and technical modifications ever since its advent 
in the early nineteenth century, the procedure plays a central 
role in establishing diagnosis in various hematological and 
systemic diseases (1,2). The standard methods of bone 
marrow sampling and BMBx have remained unchanged ever 
since its standardization in the early 1970s (1,3-5). Despite 
several breakthroughs in medicine, limited work has been 
done to develop methods/measures that would better 
control pain in patients undergoing the procedure. To date, 
BMBx remains a considerably painful procedure, with about 
half of the patients reporting severe and unbearable pain 
and discomfort during the procedure (1,6).
As modern medicine becomes patient-oriented and 
tailored to ensure each patient derives maximum benefit 
from the healthcare system, importance is given to reduce 
pain associated with medical procedures/interventions (1). 
Since there is paucity of data concerning the treatment 
and prevention of pain during BMBx, strategies to combat 
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this problem have not been systematized (1,2). There is no 
formal consensus on the optimal approach to reduce pain 
associated with BMBx. This review discusses the current 
literature available regarding this subject to summarize 
various methods that can be adopted to minimize pain 
experienced by patients undergoing bone marrow sampling.
Literature search
The PubMed database was searched for articles published 
in the English-language literature. Medical subject 
headings (MeSH) including ‘bone marrow biopsy’, ‘bone 
marrow aspiration’, ‘bone marrow trephine biopsy’, ‘bone 
marrow sampling’, ‘pain control’, ‘pain relief’, ‘discomfort’, 
‘analgesia’ were cross-referenced in the search, which was 
supplemented with a secondary manual search of PubMed, 
Ovid Medline, Google Scholar and Cochrane databases. 
Further manual searching was carried out by reviewing the 
articles listed in the references of the articles obtained from 
the primary search.
Bone marrow aspiration and biopsy
A BMBx is typically performed by a trained physician in 
a hospital, usually in an out-patient setting. The most 
common sampling site is the posterior superior iliac spine, 
followed by the anterior superior iliac crest. In the past, the 
sternum has also been used as a biopsy site, however, due 
to the risks of mediastinal injury and complications such 
as cardiac tamponade, this option is commonly kept as a 
last resort when sampling is not possible from other sites 
(7,8). Sternal puncture is also commonly used for patients 
who only require bone marrow aspiration with no need for 
trephine biopsy (8). A local anesthetic agent is administered 
to reduce sensations and minimize pain at the biopsy 
site. Some patients may also be given systemic analgesics 
and anxiolytics/sedatives before the procedure to reduce 
anxiety (9). A needle is inserted through the skin and into 
the periosteum. With twisting motion and pressure applied, 
the needle is driven through the bony cortex and into the 
marrow cavity. Most of the pain and discomfort associated 
with the procedure comes from the needle piercing through 
the periosteum. A solid, cylindrical sample of the marrow is 
removed as a trephine biopsy, followed by attachment of a 
syringe and aspiration of marrow fluid. The aspiration may 
be performed before the biopsy in some cases, depending 
on the physician practices and institutional policies (1). The 
needle is then withdrawn and pressure is applied to stop 
excessive blood loss from the sampling site. 
The posterior superior iliac spine is the preferred 
site of BMBx due to its surface prominence, safety and 
convenience. A BMBx procedure from the posterior 
superior iliac spine usually takes 10 minutes, but the 
procedure may take up to 30 minutes depending on other 
sites of biopsy (and hence their respective convenience), 
experience of the physician and co-operation of the patient 
(1,10). The patient is discharged after a brief period of 
observation following the procedure to ensure no immediate 
complications follow. Additional observation time and post-
procedural care is needed for patients who received systemic 
sedation prior to the biopsy (11). Despite its highly invasive and 
painful nature, complications are exceptionally rare and BMBx 
is generally considered a safe and low risk procedure (12).
Factors contributing to pain
Several factors have been studied to assess likelihood of 
pain and discomfort during BMBx. These include basic 
demographic factors such as age, gender, body-mass index 
(BMI) and ethnicity of the patient. There are no definitive 
correlations between the age, gender and ethnicity of the 
patient and pain during the BMBx (1). When concerning 
BMI, some studies have concluded that it plays a minimal 
role in association with pain (13,14), whereas others have 
demonstrated it to be an important factor influencing 
pain (15). Patients with a high BMI may have a thick layer of 
skin and subcutaneous tissue, making it difficult to feel the 
surface prominences of the posterior and anterior superior 
iliac crests, making the biopsy a difficult and possibly 
prolonged procedure requiring multiple punctures to gain 
access to the appropriate site. In obese patients, these sites 
may be inaccessible for a biopsy (16). Consequently, these 
patients undergo sternal puncture, which is reported to be 
the most painful site for marrow sampling and also holds a 
greater likelihood of complications (17). This may be one 
plausible explanation how BMI plays a role in determining 
pain associated with BMBx. 
Some pain-influencing factors are associated with the 
procedure itself. Reports have demonstrated a correlation 
of pain with the duration of BMBx and the difficulty of 
obtaining an adequate sample. Patients have generally 
reported lower levels of pain and discomfort when the 
BMBx is performed by an experienced physician and 
the procedure lasts for around or less than 10 minutes. 
Experienced physicians take less time to conduct a BMBx 
(14,15). Experienced physicians are also easily able to 
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overcome technical difficulties encountered during the 
procedure and are able to obtain a satisfactory sample in 
the first attempt, eliminating the need for multiple attempts 
and hence reducing overall pain (14,15). However, there 
are studies which question this notion and advocate that the 
effect of physician experience and physician technique on 
pain intensity in BMBx is minimal (13,18).
Past experience with marrow sampling is another 
important factor. Patients undergoing a difficult BMBx, 
and hence more pain, develop anticipatory anxiety which 
leads to fear and emotional distress, making future biopsies 
equally or even more painful. These patients are likely to 
report higher scores of pain in subsequent biopsies (18,19); 
hence it is important for the physician to make every effort 
to make the procedure as least painful as possible. This 
is especially important for patients with hematological 
malignancies who require repeated marrow sampling for 
assessing treatment response and prognostication (6). 
Patient knowledge and anticipation is also a noteworthy 
factor, as some studies have demonstrated that patients 
who are given incomplete information regarding BMBx, 
expected pain and adverse effects reported higher scores of 
pain (13,20).
Pharmacological agents
Before the procedure, a local anesthetic agent is infiltrated 
into the overlying skin and the periosteum of the biopsy 
site. Lidocaine, a neuronal voltage-gated sodium channel 
blocking amide, is the most commonly used agent. Other 
agents such as novocaine, ropivacaine, bupivacaine etc. 
can also be used when lidocaine is not an appropriate 
option, such as in patients with porphyrias, in which case 
bupivacaine is a safe alternative (21). Another situation 
in which lidocaine may not be appropriate would be 
hypersensitivity, though caution should be taken in regards 
to cross-reactivity with other amino-amides (9,22). The 
effectiveness of these agents, however, is limited to the skin 
and soft tissue overlying the biopsy site (6,23,24). Periosteal 
and bone anesthesia is relatively incomplete because of 
which BMBx remains a painful procedure for most patients 
with local anesthesia (LA) alone. There is lack of literature 
comparing the efficacy of one local anesthetic to another, 
and the limited data that is available shows inconsistent 
findings, not favoring the use of one agent over the other. 
For example, in a randomized trial by Kuivalainen et al. (23), 
articaine, another sodium channel blocker, with better 
bone penetration, showed no significant difference in the 
pain scores of patients in comparison to those who were 
administered lidocaine prior to BMBx. 
Local anesthetic preparations are acidic solutions, 
hence buffering them with alkaline agents is another 
method of administering LA. In a randomized trial (25), 
lidocaine buffered with sodium bicarbonate was found to be 
associated with lower pain scores than unbuffered lidocaine 
solutions, indicating it to be a superior local anesthetic for 
BMBx. However, the results of this study are questionable 
as the participating patients served as their own controls, 
undergoing bilateral BMBx with buffered lidocaine 
infiltration on one side and unbuffered on the other. This 
methodology could have had possible confounding effects 
on the results. Another randomized control trial (26) 
showed buffering lidocaine solution lessened pain and 
burning during infiltration but did not make BMBx less 
painful than unbuffered preparations. These findings 
indicate that buffering local anesthetic solutions reduces 
local irritation and pain during infiltration, but may or may 
not provide better analgesia during BMBx than unbuffered 
preparations. 
Intravenous sedation is sometimes used in conjunction 
with LA. In addition to reducing the sensation of pain, 
sedation has shown the added advantage of decreasing 
anticipatory anxiety and is frequently requested by patients 
who experienced an unbearably painful and difficult 
preceding BMBx (27). Benzodiazepines such as diazepam, 
lorazepam, midazolam etc. are the most commonly used 
sedatives (28,29). In fact, sedation with intravenous 
midazolam is routinely offered during BMBx in some 
Western countries, especially the United Kingdom (6,29). 
Randomized control trials have demonstrated better pain 
control with sedation given in conjunction with LA. Park 
et al. (30) reported that patients receiving intravenous 
lorazepam in addition to LA during BMBx reported lower 
pain scores, were more co-operative during and willing 
to undergo subsequent biopsies when needed. In another 
randomized trial (28), pediatric leukemia patients were 
assigned to receive either intravenous midazolam or 
placebo. Although both groups did not differ significantly as 
far as biopsy associated pain was concerned, it was observed 
that children receiving midazolam were less distressed and 
anxious during and after the procedure. Children in the 
midazolam group also reported markedly reduced post-
procedural pain than the controls. Other studies have 
reported significantly lower pain scores during (31) and 
after (6,32) the BMBx when sedation was used in addition 
to LA. Sedation also brings about a short-term amnesia 
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in a proportion of patients, eliminating the anxiety and 
emotional distress associated with the procedure altogether. 
This was demonstrated by Dunlop et al. (33) in a study using 
the combination a benzodiazepine with an opioid-narcotic 
and in another study using intravenous midazolam (29). 
Another similar study (34) using intravenous midazolam 
and opiates showed the same effect. However, the ability of 
different regimens to induce this effect depends on several 
factors, such as pharmacological properties, biological 
effects and efficacy of the combinations of drugs (27). 
Deep sedation with multiple agents is another strategy 
used by some physicians. The combination of ketamine 
and propofol (ketofol) has been tested for pain relief and 
sedation in pediatric patients. Due to its complimentary 
effects, ketamine has been shown to reduce the dose of 
propofol required to achieve adequate sedation during 
painful procedures (35). Since ketamine and propofol 
have opposing effects on the cardiopulmonary systems, 
this combination is also associated with fewer overall side 
effects than when each agent is used individually (35,36). 
Ketofol can produce effective procedural analgesia and 
sedation in children undergoing BMBx (37), although 
there is limited literature since it is a relatively newer agent 
in medical practice. While there are several preparations 
with varying relative concentrations of both component 
drugs, formulations with larger concentrations of ketamine 
are associated with increased the incidence of adverse 
effects such as nausea, increased recovery time and 
psychotomimetic effects (hallucinations, nightmares, etc.). 
On the other hand, combinations with lowers doses of 
ketamine relative to propofol provide equally adequate 
sedation and analgesia with shorter recovery time and 
decreased psychotomimetic side effects, and may be a 
more appropriate choice, especially in pediatric patients 
(35,38-40). The advantages of reducing required dose, 
decreased side effects and shorter recovery time with 
equally effective pain relief have also been demonstrated by 
adding fentanyl to propofol (41). 
In a retrospective report by Burkle et al. (42), the safety 
of deep sedation with midazolam, propofol and fentanyl 
was studied. No differences were observed between the 
two groups, other than the deep sedation group being 
less likely to require blood transfusions. Although the 
benefits of sedation are evident in several studies, the 
drawbacks and risks associated with it need to be kept in 
mind. There is an increased risk of adverse events with 
patients receiving sedatives. There is a substantial risk of 
respiratory depression, aspiration and aspiration pneumonia 
associated with sedation, as well as other complications such 
as hemodynamic instability, arrhythmias and even cardiac 
arrest (43,44). This not only prolongs the post-procedural 
hospital stay but also necessitates the use of additional 
monitoring equipment and hospital staff to keep adverse 
events to a minimum (6,42). For example, in one study, 
up to 19% of patients receiving intravenous midazolam 
required flumazenil to reverse sedation due to respiratory 
depression (29). As current medical practice becomes 
progressively individualized, physicians need to balance 
the advantages of using sedatives against the risk of adverse 
effects for each patient to ensure the least painful BMBx 
with the lowest possible risk of complications.
Although most of the pain and discomfort of BMBx 
arises from the puncture to gain entry into the marrow 
cavity, a considerable amount comes from the suction and 
aspiration of marrow fluid, one which is not affected by 
LA (1). In a prospective study by Vanhelleputte et al. (15), 
when compared with the placebo group, patients receiving 
tramadol prior to the procedure reported less intensity in 
pain during the aspiration phase of the BMBx, indicating 
that the pain associated with vacuum aspiration of marrow 
is responsive to opioids. In this study, tramadol given as a 
50 mg dose one hour before the procedure proved 
beneficial, with mild sedation and transient dizziness 
being the only reported side effects to the medication. 
Since tramadol lacks unwanted inhibitory effects on the 
cardiopulmonary systems, it is considered to be the safest 
and well tolerated amongst all opioid analgesics (45,46). 
Fentanyl is another opioid narcotic that has been tested for 
reducing pain during BMBx, showing benefit when used in 
combination with propofol (41). However, in a study using 
sublingual single-agent fentanyl, the pain scores of the 
fentanyl and placebo groups were similar, with side effects 
occurring frequently in the fentanyl group (47).
The mixture of nitrous oxide and oxygen, commonly 
referred to as Entonox, is a potent analgesic gas ordinarily 
used in dental procedures (48). Studies have demonstrated 
that Entonox can be self-administered by the patient 
prior to and/or during the procedure and is efficacious in 
reducing pain and discomfort during BMBx (18,49,50). A 
study by Gudgin et al. (49) showed Entonox to be equally as 
effective or better than sedation with midazolam in patients 
who had previously received the latter during past BMBx. 
Similarly, in a study by Kanagasundaram et al. (48), Entonox 
was shown to be effective in reducing pain in pediatric 
patients undergoing painful procedures (including BMBx), 
with 65% of patients having no recollection of undergoing 
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the procedure. Adverse effects were reported in only up to 
7.8% patients. While oxygen desaturation was observed in 
some patients, none of the patients developed hypoxia. In a 
comparative study (50) with lidocaine, Entonox used as an 
adjuvant to LA showed better pain control than LA alone. 
Entonox has the added benefits of being less costly, easy to 
administer and requiring minimal supervision. Vomiting, 
dysphoria, diffusion hypoxia are known adverse effects of 
Entonox, however, studies involving the agent as a method 
of analgesia report little to no adverse effects, reflecting on 
its safety (48-50). One study has reported the mean time 
to recovery from the effects of the agent being as short as 
3 minutes (48). A vast majority of patients show satisfaction 
with Entonox, with up to 84% patients admitting to 
consider this method of analgesia during future biopsies. 
These findings indicate that Entonox is a short-acting 
analgesic which is a reasonable adjuvant to LA to minimize 
pain during BMBx. Chakupurakal et al. compared the pain 
relieving effects of Entonox with intravenous midazolam (29). 
Although both agents produced pain relieving effects in 
their respective group of patients, midazolam proved to 
be superior in terms of relieving anxiety during BMBx, 
pain relief during and after the procedure, as well as post-
procedural amnesia. It is, however, noteworthy that up 
to 19% of patients in the midazolam arm experienced 
respiratory depression, necessitating the use of flumazenil 
to reverse the sedation. On the other hand, the prominent 
side effect associated with Entonox use was mild, transient 
dizziness. Although Entonox may not be as potent as 
midazolam, its relatively low cost, patients not requiring 
medical observation, prolonged hospital stay or antidotes 
to reverse its effects make it an attractive choice to provide 
patients pain relief and comfort during BMBx (50).
Methoxyflurane is another inhalation anesthetic that 
can be used to provide pain relief in this context. In a 
recent randomized control trial by Spruyt et al. (51), its 
efficacy and safety regarding pain control during BMBx 
was tested. In comparison to LA alone, adjuvant use of 
methoxyflurane provided markedly better pain control, 
reducing overall pain during BMBx and also the pain during 
bone marrow aspiration phase. However, in a subsequent 
study by Kliman et al. (52) methoxyflurane was found to 
be similar to lidocaine and nitrous oxide in relieving pain 
during BMBx. However, it is noteworthy that this study 
had a very low response rate of 16% amongst approached 
patients, which may account for the inconsistent results. 
While methoxyflurane proves to be a potent, rapidly acting 
analgesic, it has an extensive side effect profile, including 
inhibitory effects on the cardiopulmonary systems and 
nephrotoxicity. In above mentioned studies, patients 
receiving the inhalant were more likely to suffer from side 
effects, with up to 20.4% patients suffering from adverse 
effects, albeit mild to moderate in nature (51,52). Carefully 
designed, prospective studies need to be conducted to gauge 
the efficacy and safety of methoxyflurane for analgesic use 
in this context. 
Non-pharmacological strategies
As mentioned earlier, patient anxiety and distress are 
important determinants influencing pain. In a prospective 
survey by Degen et al. (13), information provided prior 
to the biopsy had a significant effect on the level of pain 
experienced by the patient. Patients who reported severe 
and unbearable pain reported to be given inadequate or 
incomplete information by the physician performing the 
biopsy. Building a good rapport with the patient, providing 
accurate and comprehensible information and ensuring 
privacy and maximum possible comfort are fundamental 
aspects of the physician-patient relationship that can lower 
patient anxiety and apprehension prior to the procedure. 
This represents an effortless approach to reducing pain 
during BMBx, as incomplete information provided at any 
point has been correlated with the likelihood of severe pain. 
Patients who have adequate knowledge about what the 
experience is going to be like, either from the information 
provided by the physician or from a previous BMBx, are 
able to better anticipate what the procedure entails in order 
to distract themselves from the pain as much as possible 
and as a result, reduce the associated pain through mental 
strategies and psychological coping mechanisms (13).
Another method to reduce pain is to use different kinds 
of biopsy needles and devices, ones that inflict less pain 
without compromising specimen retrieval and quality. A 
notable example of this approach is the Goldenberg snare-
coil BMBx needle. This device incorporates a spiral-shaped 
snare within the needle that allows for capturing of the 
bone marrow with a simple twist of a lever in the handle. 
The needle can then be withdrawn with the sample, without 
the need for manipulating the needle within the bone of the 
patient to obtain an adequate specimen, as is needed in case 
of a conventional BMBx, effectively eliminating the pain 
and discomfort associated with this step (53). The snare-
coil needle was tested in a study published in 2001 (54). Of 
the fifty biopsies done in this study, the specimens retrieved 
demonstrated intact bone marrow tissue and architecture 
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which were adequate to establish pathological diagnosis in 
all cases. This reflects on the snare-coil needle’s reliability 
to retrieve intact and adequate specimens to assist in the 
diagnosis of patients. However, studies comparing this 
device with the conventional BMBx needle are lacking. The 
superiority of the snare-coil needle needs to be objectively 
established through prospective studies of randomized 
trial design.
The OnControl Bone Marrow (OBM) Biopsy System 
represents another potential alternative to the traditional, 
manual technique of BMBx for reducing pain and 
discomfort. A battery-powered drill is used to insert the 
biopsy needle into the anterior superior iliac crest for 
extraction of bone marrow (55). One of the earliest studies 
investigating the OBM technique reported it to be a 
quick and convenient method of bone marrow sampling 
associated with low pain scores and no complications (56). 
Several subsequent studies have also demonstrated the 
OBM technique to be easier and faster in comparison to 
the manual technique of BMBx (57-59). Not only this, but 
these studies also showed that OBM was associated with 
substantially reduced pain scores from patients. Samples 
obtained via OBM technique were larger and of superior 
quality, providing more tissue for diagnosis, increasing 
diagnostic yield and accuracy and eliminating the need for 
repeat procedures, making it an attractive method of bone 
marrow sampling not only for producing less pain and 
discomfort but also for yielding adequate tissue samples to 
increase the accuracy of diagnostics in patients.
Other non-pharmacological strategies have also been 
explored in their ability to reduce pain during BMBx. 
Hypnosis and cognitive behavioral therapy (CBT) are 
examples of such alternative methods. In a randomized 
control trial involving pediatric patients undergoing 
BMBx (60), CBT and hypnosis were compared with 
controls. Patients receiving either CBT or hypnosis 
reported significantly less pain and discomfort than 
did the controls. Although CBT and hypnosis were 
equally as effective, patients in the CBT group showed 
more behavioral distress and anxiety than those in the 
hypnosis group. Accardi and Milling (61) conducted 
a methodological literature review, demonstrating the 
superiority of hypnosis in controlling pain and discomfort 
when used in conjunction with LA than other ways such 
as distracting techniques and LA alone. Hypnosis was also 
found to be efficacious in alleviating pain during other 
invasive procedures such as lumbar punctures and post-
surgical pain. The aforementioned studies examined the 
utility of these methods in pediatric and adolescent age 
groups, indicating that CBT and hypnosis were reasonable 
strategies in preparing pediatric and adolescent patients 
for BMBx to reduce pain and discomfort. A randomized 
control trial (62) testing the effectiveness of hypnosis in 
adults undergoing BMBx showed reduce anxiety in patients 
during the procedure, although the pain scores did not 
differ significantly between the hypnosis and standard of 
care groups, indicating hypnosis is not as effective in adult 
patients as it is in younger age groups. This highlights that 
hypnosis, as a method of pain control during BMBx can 
be more effective for pediatric patients, as children can be 
more suggestible and have raised susceptibility to hypnosis 
in comparison to adults (63).
Other approaches, such as music therapy, have also been 
tested. In a randomized trial by Shabanloei et al. (64), music 
therapy was shown to be associated with lower levels of 
pain and anxiety during the procedure when combined with 
LA during BMBx. Other ways, such as providing nature 
screens coupled with nature sounds, provide distraction and 
consequently reduce pain and anxiety associated with BMBx.
Another tested modality is transcutaneous electric nerve 
stimulation (TENS). In a recent randomized control trial, 
Tucker et al. (65), investigated the utility of TENS during 
BMBx as an adjunctive method of pain relief in addition 
to standard techniques. Patients in the intervention group 
stated satisfaction with TENS and would recommend 
others to use the same modality during BMBx. However, 
these reports were purely subjective and objective 
comparison using the numerical pain rating scales failed 
to show any benefit. This indicates that TENS provides 
a subjective benefit to patients; whether it can provide 
objectively superior pain relief needs to be explored through 
further studies.
Magnetic acupressure has also been tried as a non-
pharmacological method of pain relief during BMBx (66). 
Although not shown to bring about a substantial decrease 
in median pain scores of the patients, it did reduce the 
proportion of patients who reported severe pain during 
the biopsy. Since this is an inexpensive and well tolerated 
modality that requires minimal training, its applicability 
in this patient population needs to be confirmed through 
prospective studies involving a large sample sizes.
Conclusions
Despite several modifications and different protocols, BMBx 
remains an extremely painful and uncomfortable procedure 
for most patients. LA by infiltration with sodium channel 
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blockers, such as lidocaine is the most basic and widely 
used means of providing analgesia, however, pain relief 
is limited and does not affect the severe pain associated 
with bone puncture and marrow aspiration. Buffered local 
anesthetic solutions are associated with reduced pain and 
discomfort during infiltration but may or may not provide 
better analgesia during the actual biopsy. Sedation during 
the procedure significantly reduces anticipatory anxiety, 
provides better pain control and even produces short term 
amnesia regarding the BMBx. Benzodiazepines are most 
commonly used for sedation, although hypnotics, such 
as propofol, have also been used. However, side effects 
are significant with sedation, including cardiopulmonary 
depression, requiring prolonged hospital stay and additional 
healthcare staff and medical equipment for monitoring. 
Combining other analgesic drugs like ketamine and 
fentanyl with sedatives such as propofol reduces the dose 
required to produce adequate sedation and pain control 
while minimizing the significant side effects. Tramadol is 
also effective in relieving pain during the procedure with 
the added benefit of significantly reducing pain caused 
specifically by marrow aspiration and minimal adverse 
effects. Methoxyflurane is another agent able to reduce 
aspiration-related pain but has a higher incidence of adverse 
effects. Entonox is a potent analgesic gas that can be self-
administered before and during the biopsy and is efficacious 
in minimizing pain during the procedure with minimal 
side effects. These methods provide pain control to varying 
degrees during the procedure. Pain control after BMBx 
is an under-explored area that may be a topic of future 
research interest. Evidence suggests that benzodiazepines 
and Entonox do provide pain relief not only during but also 
in the post-procedural period.
Non-pharmacological factors also play an important 
role in influencing pain during BMBx and are potential 
opportunities that can be used to minimize pain. Providing 
a patient with complete and comprehensible information 
can allow them to better anticipate what the entire process 
involves and better cope with and handle the pain associated 
with the procedure. Using devices that allow for specimen 
collection with minimal manipulation of the needle when 
inside the marrow cavity reduces pain associated with this 
specific step of the BMBx. The Goldenberg snare-coil 
needle is an example of such a device. Other techniques, 
such as hypnosis, CBT, music therapy etc. that provide 
distractions to patients can help them focus off the pain 
during the procedure and hence lead to better pain control. 
However, the effectiveness of these techniques greatly 
varies according to the kind of patient they are employed 
on. TENS and magnetic acupressure have also proven to 
be effective adjuvants to LA in providing pain relief during 
BMBx. All strategies for reducing pain during BMBx that 
have been tested are grouped together in Table 1.
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Table 1 Pharmacological agents and non-pharmacological methods 
for reducing pain during bone marrow aspiration and biopsy
Pharmacological agents:
Local anesthetics (sodium channel blockers) 
Lidocaine
Novocaine (Procaine)
Bupivacaine
Buffered Lidocaine preparations
Sedatives 
Benzodiazepines
Diazepam
Lorazepam
Midozolam
Amnestic/hypnotic
Propofol
Opioid analgesics
Tramadol
Ketamine (primarily an NMDA-receptor antagonist)
Fentanyl
Inhalation anesthetics
Nitrous oxide
Methoxyflurane
Combinations
Ketofol (Ketamine-propofol)
Entonox (Nitrous oxide-oxygen)
Non-pharmacological methods:
Accurate, complete and comprehensible information given 
to the patient
Ample patient counselling and rapport building
New biopsy devices inflicting less pain
Cognitive behavioural therapy
Hypnosis
Music therapy
Transcutaneous electric nerve stimulation (TENS)
Magnetic acupressure
8 Zahid. Pain relief during bone marrow biopsy 
© Annals of Palliative Medicine. All rights reserved. Ann Palliat Med 2015www.amepc.org/apm
Footnote
Conflicts of Interest: The author has no conflicts of interest to 
declare.
References
1. Hjortholm N, Jaddini E, Hałaburda K, et al. Strategies 
of pain reduction during the bone marrow biopsy. Ann 
Hematol 2013;92:145-9.
2. Talamo G, Liao J, Bayerl MG, et al. Oral administration 
of analgesia and anxiolysis for pain associated with bone 
marrow biopsy. Support Care Cancer 2010;18:301-5. 
3. Birch CD, Fischer S, Zibell A, et al. Diagnostic bone-
marrow studies extended routinely by iliac crest biopsy, 
using the method of Schaadt-Fischer. Acta Pathol 
Microbiol Immunol Scand A 1982;90:229-34.
4. Ellis LD, Jensen WN, Westerman MP. Needle biopsy of 
bone and marrow; an experience with 1,445 biopsies. Arch 
Intern Med 1964;114:213-21.
5. Jamshidi K, Windschitl HE, Swaim WR. A new biopsy 
needle for bone marrow. Scand J Haematol 1971;8:69-71.
6. Watmough S, Flynn M. A review of pain management 
interventions in bone marrow biopsy. J Clin Nurs 
2011;20:615-23. 
7. Bichel J. Serious complications of sternal puncture. Ugeskr 
Laeger 1989;151:442-4.
8. Pascali VL, Lazzaro P, Fiori A. Is sternal bone marrow 
needle biopsy still a hazardous technique? Report of three 
further fatal cases. Am J Forensic Med Pathol 1987;8:42-4.
9. Riley RS, Hogan TF, Pavot DR, et al. A pathologist’s 
perspective on bone marrow aspiration and biopsy: I. 
Performing a bone marrow examination. J Clin Lab Anal 
2004;18:70-90.
10. Hernández-García MT, Hernández-Nieto L, Pérez-
González E, et al. Bone marrow trephine biopsy: anterior 
superior iliac spine versus posterior superior iliac spine. 
Clin Lab Haematol 1993;15:15-9.
11. Bain BJ. Bone marrow trephine biopsy. J Clin Pathol 
2001;54:737-42.
12. Steinke B. Complications after bone marrow biopsy. Dtsch 
Med Wochenschr 1992;117:1003-4.
13. Degen C, Christen S, Rovo A, et al. Bone marrow 
examination: a prospective survey on factors associated 
with pain. Ann Hematol 2010;89:619-24.
14. Kuball J, Schuz J, Gamm H, et al. Bone marrow punctures 
and pain. Acute Pain 2004;6:9-14.
15. Vanhelleputte P, Nijs K, Delforge M, et al. Pain during 
bone marrow aspiration: prevalence and prevention. J Pain 
Symptom Manage 2003;26:860-6.
16. Bain BJ. Bone marrow biopsy morbidity and mortality. Br 
J Haematol 2003;121:949-51.
17. Knowles S, Hoffbrand AV. Bone-marrow aspiration and 
trephine biopsy (1). Br Med J 1980;281:204-5.
18. Johnson H, Burke D, Plews C, et al. Improving the 
patient’s experience of a bone marrow biopsy - an RCT. J 
Clin Nurs 2008;17:717-25.
19. Brunetti GA, Tendas A, Meloni E, et al. Pain and 
anxiety associated with bone marrow aspiration and 
biopsy: a prospective study on 152 Italian patients 
with hematological malignancies. Ann Hematol 
2011;90:1233-5.
20. Audran M, Maury E, Bouvard B, et al. Is transiliac bone 
biopsy a painful procedure? Clin Nephrol 2012;77:97-104. 
21. Jensen NF, Fiddler DS, Striepe V. Anesthetic 
considerations in porphyrias. Anesth Analg 1995;80:591-9.
22. Gall H, Kaufmann R, Kalveram CM. Adverse reactions 
to local anesthetics: analysis of 197 cases. J Allergy Clin 
Immunol 1996;97:933-7.
23. Kuivalainen AM, Niemi-Murola L, Widenius T, et al. 
Comparison of articaine and lidocaine for infiltration 
anaesthesia in patients undergoing bone marrow aspiration 
and biopsy. Eur J Pain 2010;14:160-3. 
24. Holdsworth MT, Raisch DW, Winter SS, et al. Pain 
and distress from bone marrow aspirations and lumbar 
punctures. Ann Pharmacother 2003;37:17-22.
25. Ruegg TA, Curran CR, Lamb T. Use of buffered lidocaine 
in bone marrow biopsies: a randomized, controlled trial. 
Oncol Nurs Forum 2009;36:52-60.
26. Kuivalainen AM, Ebeling F, Rosenberg P. Warmed and 
buffered lidocaine for pain relief during bone marrow 
aspiration and biopsy. A randomized and controlled trial. 
Scand J Pain 2014;5:43-7.
27. Milligan DW, Howard MR, Judd A. Premedication with 
lorazepam before bone marrow biopsy. J Clin Pathol 
1987;40:696-8.
28. Friedman AG, Mulhern RK, Fairclough D, et al. 
Midazolam premedication for pediatric bone marrow 
aspiration and lumbar puncture. Med Pediatr Oncol 
1991;19:499-504.
29. Chakupurakal G, Delgado J, Nikolousis E, et al. 
Midazolam in conjunction with local anaesthesia is 
superior to Entonox in providing pain relief during 
bone marrow aspirate and trephine biopsy. J Clin Pathol 
2008;61:1051-4.
30. Park SH, Bang SM, Nam E, et al. A randomized double-
9Annals of Palliative Medicine, 2015
© Annals of Palliative Medicine. All rights reserved. Ann Palliat Med 2015www.amepc.org/apm
blind placebo-controlled study of low-dose intravenous 
Lorazepam to reduce procedural pain during bone marrow 
aspiration and biopsy. Pain Med 2008;9:249-52.
31. Giannoutsos I, Grech H, Maboreke T, et al. Performing 
bone marrow biopsies with or without sedation: a 
comparison. Clin Lab Haematol 2004;26:201-4.
32. Mainwaring CJ, Wong C, Lush RJ, et al. The role of 
midazolam-induced sedation in bone marrow aspiration/
trephine biopsies. Clin Lab Haematol 1996;18:285-8.
33. Dunlop TJ, Deen C, Lind S, et al. Use of combined 
oral narcotic and benzodiazepine for control of pain 
associated with bone marrow examination. South Med J 
1999;92:477-80.
34. Fay M, Murphy PT. Sedation with intravenous midazolam 
and intravenous opiate is superior to intravenous 
midazolam alone for bone marrow biopsy procedures. Clin 
Lab Haematol 2004;26:365.
35. Chiaretti A, Ruggiero A, Barbi E, et al. Comparison 
of propofol versus propofol-ketamine combination 
in pediatric oncologic procedures performed by non-
anesthesiologists. Pediatr Blood Cancer 2011;57:1163-7.
36. Habibi MR, Hasanzadeh Kiabi F, Soleimani A, et al. 
Sedation and analgesia during bone marrow aspiration in 
children: Is ketamine and propofol combination (Ketofol) 
an appropriate agent? Indian J Med Paediatr Oncol 
2013;34:337-9.
37. da Silva PS, de Aguiar VE, Waisberg DR, et al. Use of 
ketofol for procedural sedation and analgesia in children 
with hematological diseases. Pediatr Int 2011;53:62-7. 
38. Daabiss M, Elsherbiny M, Alotibi R. Assessment of 
different concentration of Ketofol in procedural operation. 
BJMP 2009:2;27-31.
39. Hashemi A, Ayatolahi V, Ghilian R, et al. Ketofol for bone 
marrow aspiration and lumbar puncture in children with 
ALL. Iran J Ped Hematol Oncol 2011;1:126-32. 
40. Ghadami Yazdi A, Ayatollahi V, Hashemi A, et al. Effect of 
two Different Concentrations of Propofol and Ketamine 
Combinations (Ketofol) in Pediatric Patients under 
Lumbar Puncture or Bone Marrow Aspiration. Iran J Ped 
Hematol Oncol 2013;3:187-92. 
41. Anghelescu DL, Burgoyne LL, Faughnan LG, et al. 
Prospective randomized crossover evaluation of three 
anesthetic regimens for painful procedures in children 
with cancer. J Pediatr 2013;162:137-41.
42. Burkle CM, Harrison BA, Koenig LF, et al. Morbidity 
and mortality of deep sedation in outpatient bone marrow 
biopsy. Am J Hematol 2004;77:250-6.
43. Becker DE, Haas DA. Management of complications 
during moderate and deep sedation: respiratory and 
cardiovascular considerations. Anesth Prog 2007;54:59-
68; quiz 69.
44. Mendelson WB, Thompson C, Franko T. Adverse 
reactions to sedative/hypnotics: three years’ experience. 
Sleep 1996;19:702-6.
45. Desmeules JA. The tramadol option. Eur J Pain 2000;4 
Suppl A:15-21.
46. Scott LJ, Perry CM. Tramadol: a review of its use in 
perioperative pain. Drugs 2000;60:139-76.
47. Kuivalainen AM, Ebeling F, Rosenberg PH. Pre-
medication with sublingual fentanyl did not relieve pain 
associated with bone marrow aspiration and biopsy: a 
randomized feasibility trial. Eur J Pain 2013;17:1357-64. 
48. Kanagasundaram SA, Lane LJ, Cavalletto BP, et al. 
Efficacy and safety of nitrous oxide in alleviating pain 
and anxiety during painful procedures. Arch Dis Child 
2001;84:492-5.
49. Gudgin EJ, Besser MW, Craig JI. Entonox as a sedative 
for bone marrow aspiration and biopsy. Int J Lab Hematol 
2008;30:65-7.
50. Steedman B, Watson J, Ali S, et al. Inhaled nitrous oxide 
(Entonox) as a short acting sedative during bone marrow 
examination. Clin Lab Haematol 2006;28:321-4.
51. Spruyt O, Westerman D, Milner A, et al. A randomised, 
double-blind, placebo-controlled study to assess the 
safety and efficacy of methoxyflurane for procedural 
pain of a bone marrow biopsy. BMJ Support Palliat Care 
2014;4:342-8.
52. Kliman D, Rugg L, Bailey S, et al. A prospective 
assessment of Methoxyflurane and other analgesic 
agents during bone marrow biopsy. Pathology-Journal 
of the RCPA 2014;46:S94. Available online: http://
journals.lww.com/pathologyrcpa/Abstract/2014/02001/
A_PROSPECTIVE_ASSESSMENT_OF_
METHOXYFLURANE_AND.260.aspx 
53. Goldenberg AS, Rishton M. Bone-marrow biopsy needle 
incorporating a snare-coil specimen-capturing device: 
description and preclinical studies. Biomed Instrum 
Technol 1999;33:522-9. 
54. Goldenberg AS, Tiesinga JJ. Clinical experience with a 
new specimen capturing bone marrow biopsy needle. Am J 
Hematol 2001;68:189-93.
55. Reed LJ, Raghupathy R, Strakhan M, et al. The 
OnControl bone marrow biopsy technique is superior 
to the standard manual technique for hematologists-in-
training: a prospective, randomized comparison. Hematol 
Rep 2011;3:e21. 
10 Zahid. Pain relief during bone marrow biopsy 
© Annals of Palliative Medicine. All rights reserved. Ann Palliat Med 2015www.amepc.org/apm
56. Cohen SC, Gore JM. Evaluation of a powered intraosseous 
device for bone marrow sampling. Anticancer Res 
2008;28:3843-6.
57. Berenson JR, Yellin O, Blumenstein B, et al. Using a 
powered bone marrow biopsy system results in shorter 
procedures, causes less residual pain to adult patients, and 
yields larger specimens. Diagn Pathol 2011;6:23. 
58. Miller LJ, Philbeck TE, Montez DF, et al. Powered bone 
marrow biopsy procedures produce larger core specimens, 
with less pain, in less time than with standard manual 
devices. Hematol Rep 2011;3:e8. 
59. Swords RT, Anguita J, Higgins RA, et al. A prospective 
randomised study of a rotary powered device (OnControl) 
for bone marrow aspiration and biopsy. J Clin Pathol 
2011;64:809-13.
60. Liossi C, Hatira P. Clinical hypnosis versus cognitive 
behavioral training for pain management with pediatric 
cancer patients undergoing bone marrow aspirations. Int J 
Clin Exp Hypn 1999;47:104-16.
61. Accardi MC, Milling LS. The effectiveness of hypnosis 
for reducing procedure-related pain in children and 
adolescents: a comprehensive methodological review. J 
Behav Med 2009;32:328-39. 
62. Snow A, Dorfman D, Warbet R, et al. A randomized trial 
of hypnosis for relief of pain and anxiety in adult cancer 
patients undergoing bone marrow procedures. J Psychosoc 
Oncol 2012;30:281-93. 
63. Morgan AH, Hilgard ER. Age differences in susceptibility 
to hypnosis. Int J Clin Exp Hypn 1973;21:78-85.
64. Shabanloei R, Golchin M, Esfahani A, et al. Effects 
of music therapy on pain and anxiety in patients 
undergoing bone marrow biopsy and aspiration. AORN J 
2010;91:746-51. 
65. Tucker DL, Rockett M, Hasan M, et al. Does 
transcutaneous electrical nerve stimulation (TENS) 
alleviate the pain experienced during bone marrow 
sampling in addition to standard techniques? A 
randomised, double-blinded, controlled trial. J Clin Pathol 
2015;68:479-83.
66. Bao T, Ye X, Skinner J, et al. The analgesic effect of 
magnetic acupressure in cancer patients undergoing 
bone marrow aspiration and biopsy: a randomized, 
blinded, controlled trial. J Pain Symptom Manage 
2011;41:995-1002.
Cite this article as: Zahid MF. Methods of reducing pain 
during bone marrow biopsy: a narrative review. Ann Palliat Med 
2015. doi: 10.3978/j.issn.2224-5820.2015.09.02
View publication stats
